Racism and Homophobia in Health Care Settings May Reduce PrEP Uptake for Young Black Gay and Bisexual Men, Study Finds

Racism and Homophobia in Health Care Settings May Reduce PrEP Uptake for Young Black Gay and Bisexual Men, Study Finds

Racial segregation and medical mistrust in Milwaukee may keep pre-exposure prophylaxis out of their hands.

IAS 2019: What to Expect in HIV Science

Next week, 6,000 HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

By Sony Salzman

This Week in HIV Research: Cracking the Contraception Conundrum

July 11, 2019: Seroconversion while on long-acting contraceptives; cardiovascular risk in people with HIV; suboptimal testing in high-prevalence U.S. areas; E/C/F/TAF may be suitable for PEP.

By Barbara Jungwirth and Myles Helfand

In New York City, PrEP on Demand Is Now on the Menu for Men Who Have Sex With Men

On-demand pre-exposure prophylaxis may be best for people with episodic risk who cannot or would prefer not to take the pill every day.

By Mathew Rodriguez

Our Newest Posts

American College of Physicians Releases Comprehensive Transgender Care Guide

"The biggest barrier to care for transgender people is a lack of knowledgeable providers," said lead author Joshua D. Safer, M.D., with Mount Sinai Medical System.

By Sony Salzman

This Week in HIV Research: Weighing Anchor on NRTI-Free Treatment

June 27, 2019: Long-term viability of NRTI-free salvage therapy; factors associated with HIV treatment interruption; evolution of frailty risk among older people; skin and soft tissue infections among people with HIV.

By Barbara Jungwirth and Myles Helfand

Can Self-Swabs Make HIV Exposure and Risk Reporting More Accurate?

Could home-based self-swabs and mobile technology be helpful tools in the future of HIV prevention?

By Sony Salzman

After Pilot, Whitman-Walker Health Establishes Same-Day HIV Treatment Start Program

"We're very much putting the patient in the driver's seat," said Heather Alt, deputy director of nursing with Whitman-Walker. "If folks didn't feel ready, we would not push them to start."

By Kenyon Farrow

Underwhelming Results From Hepatitis C Vaccine Trial

The 548-person U.S. study found that chronic hepatitis C infection occurred among an identical number of people who received the experimental vaccine compared to people who received a placebo.

By U.S. Department of Health and Human Services

Refer your clients and patients to TheBody, TheBodyPro's sibling site for people living with or affected by HIV. TheBody delivers vital information, news, support, and personal perspectives on HIV and related issues.